A Vintage Dish With Modern Appeal
LendingClub Gains 8%
Shares of the California-based fintech company LendingClub Corp. (LC) are currently trading at $31.07, up $2.45 or 8.58%, with trading volume of over 657K versus an average volume of 2.41 million shares. The stock has been trading in the range of $4.40 – $33.30 for the past one year.
The company is scheduled to release its Q3 results on Wednesday, October 27, 2021, after-market hours. Analysts polled by Thomson Reuters expect earnings of $0.03 per share and revenue of $221.19 million for the quarter. Analysts’ estimate typically exclude certain special items.
COVID-19: UK records 127 coronavirus deaths and 36,060 new cases, daily figures show
The UK has recorded another 127 coronavirus-related deaths and a further 36,060 infections in the latest 24-hour period, government figures show.
Where the Suburbs End
A single-family home from the 1950s is now a rental complex and a vision of California’s future.
ChemoCentryx Surges 80% After FDA Approves Its Vasculitis Drug
Shares of ChemoCentryx Inc. (CCXI) surged 80% on Friday morning after the U.S. Food and Drug Administration approved the company’s vasculitis drug.
CCXI is currently trading at $35.04, up $15.44 or 78.78%, on the Nasdaq, on a volume of 15.2 million shares, above average volume of 1.8 million shares. The stock has traded between $9.53 and $70.29 in the past 52 week period.
ChemoCentryx said FDA approved Tavneos (avacopan), an orally administered selective complement 5a receptor inhibitor, as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis, specifically granulomatosis with polyangiitis and microscopic polyangiitis, in combination with standard therapy.
According to Mayo Clinic, vasculitis involves inflammation of the blood vessels. The inflammation can cause the walls of the blood vessels to thicken, which reduces the width of the passageway through the vessel. If blood flow is restricted, it can result in organ and tissue damage.
Tavneos is expected to be made available to clinicians and patients in the next few weeks.
Roche’s Rituximab is the only other FDA-approved therapy for adult patients with GPA and MPA.
UK Manufacturing Upturn Slows In September
The UK manufacturing sector upturn slowed in September as supply chain delays, slow new order growth and higher cost weighed on production, final data from IHS Markit showed on Friday.
The final Chartered Institute of Procurement & Supply manufacturing Purchasing Managers’ Index fell to a seven-month low of 57.1 in September from 60.3 in August. The flash reading was 56.3.
Production increased at the slowest pace since February. Upturns at medium and large-scale producers were offset by a continued downturn among small firms.
Production schedules were disrupted by a combination of input shortages, longer supplier lead times and capacity constraints.
New orders also rose at the weakest pace since February as export orders contracted for the first time in eight months.
Manufacturers continued to report labor shortages and difficulties recruiting appropriately skilled staff during September.
Manufacturers maintained a positive outlook for the year ahead in September. Over 62 percent of companies forecast their output would increase during the coming twelve months.
On the price front, data showed that both input and selling prices continued to surge higher.
“The September PMI highlights the risk of the UK descending towards a bout of ‘stagflation’, as growth of manufacturing output and new orders eased sharply while input costs and selling prices continued to surge higher,” Rob Dobson, director at IHS Markit, said.
Poland says it will continue to work on global tax deal
WARSAW, Oct 8 (Reuters) – Poland is among countries that have decided to continue working on implementing a global tax deal including a minimum 15% global corporate tax rate, the finance ministry said on Friday.
“Negotiations at the OECD forum were demanding, but we are still working and we want to jointly create a new tax reality in the world,” Polish Finance Minister Tadeusz Koscinski said in a statement.
“The global tax should not lead to an increase in taxation of foreign companies that invest in Poland and conduct real economic activity here… It was our condition to start further work on the global taxation project.”
Pre-market Movers: GOVX, ITRM, GREE, RGS, MTNB…
The following are some of the stocks making big moves in Wednesday’s pre-market trading (as of 6.00 A.M. EDT).
In the Green
GeoVax Labs, Inc. (GOVX) is up over 33% at $5.57
Iterum Therapeutics plc (ITRM) is up over 20% at $0.67
Greenidge Generation Holdings Inc. (GREE) is up over 15% at $27.50
Regis Corporation (RGS) is up over 10% at $4.55
Matinas BioPharma Holdings, Inc. (MTNB) is up over 10% at $1.56
Lucid Group, Inc. (LCID) is up over 9% at $26.78
Editas Medicine, Inc. (EDIT) is up over 6% at $55.92
Sarcos Technology and Robotics Corporation (STRC) is up over 6% at $9.50
U.S. Well Services, Inc. (USWS) is up over 6% at $0.89
Molecular Data Inc. (MKD) is up over 5% at $0.31
In the Red
PetroChina Company Limited (PTR) is down over 5% at $47.30
ABVC BioPharma, Inc. (ABVC) is down over 5% at $2.75
Borqs Technologies, Inc. (BRQS) is down over 5% at $0.60
EQT Corporation (EQT) is down over 4% at $21.00
DatChat, Inc. (DATS) is down over 4% at $13.97
A Vintage Dish With Modern Appeal
Inspired by German Hamburg steak, Japanese hambagu and other seasoned patties of the world, this hamburger steak plate delivers a kind of nostalgic comfort.
By Eric Kim